CORE--DEVELOPMENTAL FUNDS

$0P30FY2002CANIH

University Of Chicago, Chicago IL

Investigators

Linked publications & trials

Paper 39661064 Paper 39579248 Paper 39438113 Paper 39374047 Paper 39270007 Paper 39141403 Paper 39114540 Paper 39108474 Paper 39071306 Paper 39069988 Paper 38883758 Paper 38881356 Paper 38849889 Paper 38810242 Paper 38771643 Paper 38752924 Paper 38735044 Paper 38716867 Paper 38691450 Paper 38632339 Paper 38561491 Paper 38548994 Paper 38536082 Paper 38533736 Paper 38496521 Paper 38427437 Paper 38421866 Paper 38381713 Paper 38294692 Paper 38294689 Paper 38293065 Paper 38219706 Paper 38213818 Paper 38190286 Paper 38186960 Paper 38175791 Paper 38155245 Paper 38128533 Paper 38128531 Paper 38014221 Paper 37981977 Paper 37963369 Paper 37961427 Paper 37904839 Paper 37897729 Paper 37839663 Paper 37721526 Paper 37702745 Paper 37688780 Paper 37679570 Paper 37676735 Paper 37635106 Paper 37630292 Paper 37581644 Paper 37578238 Paper 37494818 Paper 37455161 Paper 37351172 Paper 37316584 Paper 37292972 Paper 37273411 Paper 37254839 Paper 37179373 Paper 37096305 Paper 37069665 Paper 37066154 Paper 37028112 Paper 37020993 Paper 36997341 Paper 36862086 Paper 36851600 Paper 36840977 Paper 36811968 Paper 36795484 Paper 36792123 Paper 36759711 Paper 36725889 Paper 36681685 Paper 36571231 Paper 36550307 Paper 36524978 Paper 36302963 Paper 36240687 Paper 36227917 Paper 36206753 Paper 36177650 Paper 36138472 Paper 36130227 Paper 36125275 Paper 35995095 Paper 35977099 Paper 35962531 Paper 35952624 Paper 35914239 Paper 35897143 Paper 35880981 Paper 35869336 Paper 35792927 Paper 35674134 Paper 35665495

Abstract

DESCRIPTION: Over the next grant period, we are requesting funds for: a) recruitment of new investigators, b) program development/Program Grant Project and c) development of new core facilities. We will emphasize population science recruitment with an initial focus on a senior investigator as Associate Director for Population Science, followed by 1-2 junior faculty in epidemiology, behavioral science, prevention and/or other areas of cancer control. Programs 1, 2, 3, 4, 6 and 7 are also targeted for new translational investigator support, i.e., hematopathology, phase I, head and neck cancer, immunology, GU oncology, and molecular biology. The second target for developmental funds is program development with the goal of increasing the cohesiveness of the programs. Each year, funds will be allocated to each of two selected programs for the support of two pilot projects per program. An additional amount will be committed to translational projects competed across the other five programs. For the first year of the new grant period, GU Oncology and Clinical Cancer Genetics and Prevention Programs, the newest UCCRC programs, will be targeted. The third use of these funds will be the development of new shared resources identified as key to new research initiatives. These facilities include: human tissue procurement (HTP), proteomics/structural biology, production of clinical grade immunological reagents and/or drugs (a Good Manufacturing Process-GMP facility) and PET, CT or other radiological or physiological instruments for tumor response assessment to the new generation of targeted therapies. It is anticipated that as the need for other new technologies is identified, CCSG developmental funds will be applied to their development.

View original record on NIH RePORTER →